These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4419179)
1. [Effect of a new lipid-reducing preparation in case of hyperlipoproteinemia]. Knüchel F Med Welt; 1974 Oct; 25(43):1766-9. PubMed ID: 4419179 [No Abstract] [Full Text] [Related]
2. [Pharmacological treatment of primary hyperlipoproteinemia]. Ciświcka-Sznajderman M Pol Tyg Lek; 1976 Feb; 31(7):289-91. PubMed ID: 768941 [No Abstract] [Full Text] [Related]
3. [Treatment of hyperlipoproteinemia in relation to recent classifications]. Cloarec M Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215 [No Abstract] [Full Text] [Related]
4. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia]. Huth K; Blumenthal J; Schmahl FW Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868 [No Abstract] [Full Text] [Related]
6. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy]. Schwartzkopff W; Zschiedrich M Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436 [No Abstract] [Full Text] [Related]
7. [Pharmacological treatment of hyperlipoproteinemias--theory and practice]. Frisk-Holmberg M Lakartidningen; 1974 Aug; 71(34):3083-6. PubMed ID: 4410383 [No Abstract] [Full Text] [Related]
8. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
10. [New aspects of the therapy of arteriosclerosis]. Avogaro P; Capri C; Cazzolato G Recenti Prog Med; 1971 Nov; 51(5):455-70. PubMed ID: 5172398 [No Abstract] [Full Text] [Related]
11. [Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients]. Rufli T; Stähelin H Dermatologica; 1972; 144(5):270-82. PubMed ID: 4351630 [No Abstract] [Full Text] [Related]
12. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study]. Schäfer B; Kluthe R Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394 [No Abstract] [Full Text] [Related]
13. [Familial type V hyperlipoproteinemia]. Dyerberg J Ugeskr Laeger; 1975 Jan; 137(2):89. PubMed ID: 164072 [No Abstract] [Full Text] [Related]